Perspective Therapeutics, Inc. (CATX)
0.784
0.00 (0.00%)
USD |
NYAM |
Nov 19, 09:43
Perspective Therapeutics Price to Book Value : 0.3037 for Nov. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 0.3022 |
| November 17, 2026 | 0.3331 |
| November 16, 2026 | 0.3579 |
| November 13, 2026 | 0.3654 |
| November 12, 2026 | 0.3264 |
| November 11, 2026 | 0.3197 |
| November 10, 2026 | 0.3047 |
| November 09, 2026 | 0.3315 |
| November 06, 2026 | 0.3254 |
| November 05, 2026 | 0.3054 |
| November 04, 2026 | 0.3371 |
| November 03, 2026 | 0.3409 |
| November 02, 2026 | 0.4029 |
| October 30, 2026 | 0.4455 |
| October 29, 2026 | 0.4533 |
| October 28, 2026 | 0.4843 |
| October 27, 2026 | 0.461 |
| October 26, 2026 | 0.4688 |
| October 23, 2026 | 0.6237 |
| October 22, 2026 | 0.8755 |
| October 21, 2026 | 0.891 |
| October 20, 2026 | 0.891 |
| October 19, 2026 | 0.8484 |
| October 16, 2026 | 0.8407 |
| October 15, 2026 | 0.9065 |
| Date | Value |
|---|---|
| October 14, 2026 | 0.8678 |
| October 13, 2026 | 0.8794 |
| October 12, 2026 | 0.9763 |
| October 09, 2026 | 1.030 |
| October 08, 2026 | 1.050 |
| October 07, 2026 | 0.953 |
| October 06, 2026 | 0.9143 |
| October 05, 2026 | 0.9956 |
| October 02, 2026 | 1.069 |
| October 01, 2026 | 1.054 |
| September 30, 2026 | 1.065 |
| September 29, 2026 | 0.9229 |
| September 28, 2026 | 0.8807 |
| September 25, 2026 | 0.8877 |
| September 24, 2026 | 0.8807 |
| September 23, 2026 | 0.9229 |
| September 22, 2026 | 1.043 |
| September 21, 2026 | 1.046 |
| September 18, 2026 | 1.014 |
| September 17, 2026 | 1.014 |
| September 16, 2026 | 0.9511 |
| September 15, 2026 | 0.9617 |
| September 14, 2026 | 1.029 |
| September 11, 2026 | 0.9899 |
| September 10, 2026 | 0.9758 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 1.326 |
| MiMedx Group, Inc. | 2.185 |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | 1.872 |
| Enovis Corp. | 1.044 |
Price to Book Value Related Metrics
| PS Ratio | 373.59 |
| Price | 0.784 |
| Earnings Yield | -159.2% |
| Market Cap | 89.50M |